Zunsemetinib
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
513.92
Molecular Formula
C25H22ClF2N5O3
Notes
Research use only, not for human use.
Receptor
MAPK
CAS Number
1640282-42-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS636334-01 0.01 mg
Plk3, Recombinant, Human, N-terminal His tag, Serine Threonine Kinase, aa 58-339 (CNK, FNK, PRK, Polo-like kinase 3)
Ask
View Details MBS636334-02 5x 0.01 mg
Plk3, Recombinant, Human, N-terminal His tag, Serine Threonine Kinase, aa 58-339 (CNK, FNK, PRK, Polo-like kinase 3)
Ask
View Details MBS1390132-01 0.02 mg (E-Coli)
Recombinant Rhizobium meliloti Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details 
MBS1390132-02 0.02 mg (Yeast)
Recombinant Rhizobium meliloti Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details MBS1390132-03 0.1 mg (E-Coli)
Recombinant Rhizobium meliloti Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details MBS1390132-04 0.1 mg (Yeast)
Recombinant Rhizobium meliloti Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details